Yalun Zhang
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: Nature communications
Published: February 17, 2026
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: Nature communications
Published: February 17, 2026
Ketamine-induced Sustained Modulation of γ-Aminobutyric Acid Type A Receptor Function in Mouse Hippocampal Neurons after Anesthesia.
Journal: Anesthesiology
Published: June 09, 2025
MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
Journal: CNS neuroscience & therapeutics
Published: September 20, 2022
Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation.
Journal: The Journal of biological chemistry
Published: February 05, 2021
Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
Journal: Brain : a journal of neurology
Published: September 21, 2020
Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Journal: PloS one
Published: August 31, 2016
SORL1 mutations in early- and late-onset Alzheimer disease.
Journal: Neurology. Genetics
Published: June 13, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026